What actually happens to your body when you stop Ozempic

What did @bbcnews actually say?

The video combines personal testimony from a user and commentary from what appears to be a clinician. The central claims are that stopping GLP-1 injections causes appetite to return rapidly, sometimes "the next day," that this rebound feels like "an avalanche" or "tsunami," and that the weight regain is so predictable that the speaker believes they will "always find a way to stay on it." One contributor describes eating compulsively within three days of stopping, without conscious awareness. The framing is honest about side effects during treatment, including nausea, hair loss, and poor sleep, but the overall message tilts toward indefinite use as the only practical solution.

Does the science back this up?

The appetite rebound claim is well-supported. Multiple trials confirm that weight regain after stopping semaglutide is significant and relatively fast. The STEP 1 Extension trial (Wilding et al., 2022, Diabetes, Obesity and Metabolism) found that participants regained two-thirds of their lost weight within one year of stopping semaglutide 2.4mg. Appetite-related hormones, including GLP-1 and ghrelin, return toward baseline within weeks of discontinuation. The "tsunami" description is colorful but not scientifically inaccurate. Where the video gets murkier is the implied permanence of the problem. The suggestion that lifestyle changes alone can maintain weight loss after stopping is plausible but harder to deliver in practice than the video makes it sound.

What did they get wrong (or right)?

They got the rebound physiology largely right. The idea that appetite suppression disappears when the drug leaves your system is accurate. GLP-1 receptor agonists work while they are present; they do not retrain your hypothalamus permanently.

What is oversimplified is the "if you implement lifestyle changes, just continue them" framing. This is technically true but sidesteps a key biological reality: semaglutide changes how the brain responds to food cues. Kullmann et al. (2022, Nature Metabolism) showed that semaglutide reduced activity in reward-related brain regions in response to food. When the drug is gone, those neural responses return. Telling someone to "just continue" a calorie deficit after that shift reverses is easier said than done, and the video does not fully acknowledge that.

The hair loss mention is real. Telogen effluvium from rapid weight loss is documented, though it is usually temporary. That detail was accurate and underreported in most GLP-1 content.

What should you actually know?

Weight regain after stopping GLP-1 medications is not a personal failure. It reflects the drug's mechanism. These medications act on receptors in the brain and gut that regulate hunger signals. When you stop, those signals return. The SURMOUNT-4 trial (Aronne et al., 2024, JAMA) showed that participants who stopped tirzepatide after 36 weeks regained most of their lost weight within the following year, while those who continued lost further weight. This is consistent across the drug class.

• Stopping abruptly versus tapering has not been studied rigorously, so the "three days and then compulsive eating" anecdote is plausible but not universally documented.
• Long-term use is increasingly supported by evidence, but the decision to stay on medication indefinitely should involve a prescribing clinician who knows your full health picture.
• "Addiction" is the wrong word here clinically. Physical dependence on GLP-1 agonists is not established. What the speaker is describing is the return of a pre-existing biological drive, not withdrawal in the pharmacological sense.

Is indefinite use the only answer?

Not necessarily, but it is a legitimate option for many people. The framing that you must stay on these drugs forever to maintain results is gaining clinical traction, largely because the evidence supports it. Obesity is increasingly classified as a chronic, relapsing condition, and treating it intermittently has not worked well historically. That said, "always finding a way to stay on it" is not a clinical recommendation, it is one person's conclusion about their own situation. Individual responses vary, insurance coverage varies, and compounded versions of these drugs are not equivalent to regulated brand-name products. Anyone making this decision should be doing so with a licensed provider, not based on a TikTok video, even a well-intentioned one.